Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7–11 Years

In the MORDOR I trial, children under 5 years of age were randomized to receive biannual (every 6 months) azithromycin for 2 years in Niger, Malawi, and Tanzania. In 30 Nigerien communities, children aged 7–11 years, who were not enrolled in the MORDOR I trial to receive biannual azithromycin, were...

Descripción completa

Detalles Bibliográficos
Autores principales: Brennhofer, Stephanie A., Rogawski McQuade, Elizabeth T., Zhang, Jixian, Pholwat, Suporn, Stroup, Suzanne, Platts-Mills, James A., Liu, Jie, Houpt, Eric R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896336/
https://www.ncbi.nlm.nih.gov/pubmed/36535258
http://dx.doi.org/10.4269/ajtmh.22-0583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896336/
https://www.ncbi.nlm.nih.gov/pubmed/36535258
http://dx.doi.org/10.4269/ajtmh.22-0583

Ejemplares similares